25-Hydroxycholesterol Modulates CD163+ Macrophage Polarization in TNBC

Overview

This study identifies 25-hydroxycholesterol (25HC) as a key regulator of macrophage polarization in the immune microenvironment of triple-negative breast cancer (TNBC). The aberrant activation of the interferon signaling pathway linked to 25HC metabolism inhibits CD163+ macrophage polarization, providing insights into TNBC aggressiveness and potential therapeutic targets.

Background

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options, making it a significant clinical challenge. The tumor immune microenvironment (TIME) plays a crucial role in tumor progression, with tumor-associated macrophages (TAMs) being the most abundant immune cells. Understanding the mechanisms that regulate macrophage polarization within the TIME of TNBC is essential for developing new therapeutic strategies.

Data Highlights

No numerical data or trial data available in the article.

Key Findings

• 25-hydroxycholesterol (25HC) is identified as a critical regulator of macrophage polarization in TNBC.
• The study delineates an interferon regulatory factor 7–cholesterol-25-hydroxylase–25HC axis that inhibits CD163+ macrophage polarization.
• Macrophage polarization is linked to the unique lipid metabolic signature of TNBC.
• The findings suggest that dysregulated 25HC metabolism contributes to TNBC aggressiveness.
• This research provides a novel insight into immunometabolic mechanisms that could be targeted for therapeutic intervention in TNBC.

Clinical Implications

The identification of 25HC as a modulator of macrophage polarization highlights a potential therapeutic target for TNBC. Strategies aimed at restoring normal macrophage function or inhibiting the 25HC pathway may improve treatment outcomes in patients with this aggressive cancer subtype.

Conclusion

This study underscores the importance of the immune microenvironment in TNBC and presents 25-hydroxycholesterol as a significant factor influencing macrophage behavior, paving the way for future therapeutic developments.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- RORα: a critical nexus in the crosstalk between cholesterol metabolism and macrophage polarization
2. Frontiers in Immunology, 2026 -- Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma
3. Basic Research in Cardiology, 2016 -- The Role of CD40 in Coronary Artery Disease: Implications for Macrophage Activity
4. Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer - PubMed
5. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine
6. Basic Research in Cardiology — NLRP3 Facilitates Macrophage Proliferation Induced by Lipids in Established Atherosclerotic Conditions
7. Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer - PubMed
8. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine
9. CD163+ macrophages in the triple-negative breast tumor microenvironment are associated with improved survival in the Women’s Circle of Health Study and the Women’s Circle of Health Follow-Up Study | Breast Cancer Research | Full Text